|
FY2026
12 months to Apr 30, 2026
|
FY2025
12 months to Apr 30, 2025
|
FY2024
12 months to Apr 30, 2024
|
FY2023
12 months to Apr 30, 2023
|
FY2022
12 months to Apr 30, 2022
|
|
|---|---|---|---|---|---|
| CASH FLOW FROM OPERATING ACTIVITIES | |||||
| Net (loss) | |||||
| Net (loss)/income | |||||
| Adjustments to reconcile net (loss)/income to net cash used in operating activities | |||||
| Amortization and impairment expense | |||||
| Amortization expense on intangible assets | |||||
| Depreciation of property and equipment | |||||
| Depreciation of Right-of-use asset | |||||
| Interest expense on lease liability | |||||
| Change in fair value of derivative liability | |||||
| Shares and warrants issued for services | |||||
| Derivative expense | |||||
| Amortization of debt discounts | |||||
| Settlement expense | |||||
| Loss on settlement of accounts payable | |||||
| Loss on Financial Assets at FVTPL | |||||
| Deferred income tax benefit | |||||
| Overprovision of income tax payable | |||||
| Impairment of intangible assets credit loss expense | |||||
| Loss on write-off of investment | |||||
| Impairment loss - amount due from related party | |||||
| Impairment loss - other receivable | |||||
| Changes in assets and liabilities, net of acquired amounts | |||||
| Accounts receivables | |||||
| Inventories | |||||
| Prepaid inventory | |||||
| Prepaid expenses and other current assets | |||||
| Accounts payable and accrued expenses | |||||
| Other current assets | |||||
| Accrued interest | |||||
| Other receivables | |||||
| Prepayments and deposits | |||||
| Digital assets | |||||
| Contract costs | |||||
| Account payable | |||||
| Accrued expenses | |||||
| Contract liabilities | |||||
| Lease liabilities | |||||
| Income taxes payable | |||||
| Total adjustments | |||||
| Net cash used in operating activities of continuing operations | |||||
| Net cash used in operating activities | |||||
| CASH FLOW FROM INVESTING ACTIVITIES | |||||
| Investment, at cost | |||||
| Net cash used in investing activities of continuing operations | |||||
| Payment of increase in investment in subsidiary | |||||
| Payment of acquisition of investment in subsidiaries | |||||
| Net cash used in investing activities | |||||
| CASH FLOW FROM FINANCING ACTIVITIES | |||||
| Proceeds from private placement | |||||
| Proceeds from At-the-market transaction | |||||
| Proceeds from exercise of warrants for cash | |||||
| Proceeds from direct offering | |||||
| Amount due from related party | |||||
| Payments of notes payable | |||||
| Amount due to related party | |||||
| Net cash provided by financing activities | |||||
| Effect of exchange rate fluctuations on cash and cash equivalents | |||||
| NET INCREASE IN CASH | |||||
| CASH AND CASH EQUIVALENTS - BEGINNING OF YEAR | |||||
| CASH AND CASH EQUIVALENTS - END OF YEAR | |||||
| Interest expense | |||||
| Shares issued for contingent consideration | |||||
| Warrants granted for deferred compensation | |||||
| Amount due from related party | |||||
| Amount due to related party | |||||
Loading...